Acrivon Therapeutics, Inc.

Develops precision cancer therapies by matching patients to drugs using its proteomics platform.

ACRV | US

Overview

Corporate Details

ISIN(s):: US0048901096
LEI:
Country:: United States of America
Address:: 480 ARSENAL WAY, SUITE 100, 2472 WATERTOWN
Website:: https://acrivon.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Acrivon Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in precision oncology. The company leverages its proprietary Acrivon Predictive Precision Proteomics (AP3) platform to develop targeted cancer therapies. The AP3 platform utilizes phosphoproteomics to analyze the biologic drivers of a patient's cancer, enabling the creation of predictive 'OncoSignature' tests. This method is designed to match drug candidates with patients whose tumors are most likely to respond, aiming to improve therapeutic outcomes beyond what is achievable with genomics. Acrivon's pipeline is led by ACR-368, a selective kinase inhibitor in Phase 2 clinical trials for various solid tumors. The company also advances its internally developed programs and seeks strategic partnerships to apply its AP3 platform to co-develop predictive tests for external drug candidates.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Acrivon Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Acrivon Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Acrivon Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Soiken Holdings Inc. A bioscience group offering clinical testing, supplements, and cosmetics for pharma/food industries.	Japan	2385
Sotkamo Silver AB Mines silver, gold, and zinc in Finland to supply essential metals for green technologies.	Sweden	SOSI
Stagwell Inc A digital-first marketing network transforming brands with data, media, and creative services.	United States of America	STGW
Star Equity Holdings, Inc. A diversified holding co. in building, talent solutions, energy services, and investments.	United States of America	STRR
Stem Cells Spin Spolka Akcyjna Biotech firm commercializing proprietary MIC-1 stem cells through R&D, cultivation, and production.	Poland	SCS
STRANGER HOLDINGS PLC Mining and developing uranium and strategic metals with near-term production projects in Africa.	United Kingdom	STHP
Ströer SE & Co. KGaA A media company providing integrated out-of-home (OOH) and digital advertising solutions.	Germany	SAX
STUDIO ALICE Co.,Ltd. Specialized photo studios capturing family milestones with costumes, styling, and kimono rentals.	Japan	2305
Surrozen, Inc./DE Develops regenerative antibodies modulating the Wnt pathway to repair tissues and restore organs.	United States of America	SRZN
SUSMED, Inc. Develops digital therapeutics (DTx) and AI systems to streamline clinical development.	Japan	4263